Updated:
Surescripts
Surescripts operates the nation's largest health information network, linking more than 2.3 million healthcare professionals and provider organizations...
Surescripts
Surescripts operates the nation's largest health information network, linking more than 2.3 million healthcare professionals and provider organizations through its Master Patient Index, which spans the insured American population. Founded originally as an e-prescribing backbone, the network has evolved into a multisided platform that shares clinical, benefit, and price intelligence at scale. The company counts the majority of U.S. pharmacies, health plans, pharmacy benefit managers, EHR vendors, and prescribers as network participants, creating a data fabric that underpins medication access and clinical coordination. The network's deployment spans three core areas: intelligent prescribing, intelligent prior authorization, and value-based care. The prescribing layer automates medication safety checks at the point of care while surfacing patient-specific benefit and price information. The prior authorization module — which Surescripts expanded in 2026 to reach 50% more prescribers nationwide — enables near-touchless adjudication by pulling clinical data directly from EHRs and routing responses without fax or phone calls. Confirmed network participants include national retail pharmacy chains, leading EHR vendors, and major health plans. The network processed 30.5 billion transactions in 2025, with use cases ranging from electronic case reporting to specialty medication access and care-team messaging. The company operates adjacent services including a Prior Authorization Portal for providers whose EHRs lack native integration, an RxTransfer capability for pharmacies, and electronic case reporting that went live with pilot public-health agencies in roughly three days. Surescripts employs a cross-industry collaboration model, convening its Network Alliance of competing healthcare organizations to solve interoperability bottlenecks collectively. What structurally separates Surescripts from a conventional SaaS or data-infrastructure vendor is its stewardship mandate. The network is not a public utility, but it functions like one: it is embedded in virtually every U.S. prescribing and insurance-benefit workflow, yet it operates through a collaborative governance model that requires pharmacy chains, health plans, and technology vendors to share intelligence through a single, neutral interoperability layer. That architecture makes Surescripts the default consensus mechanism for medication-related data exchange in the United States.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Arlington
Corporate office
Arlington, VA, United States
Sector focus
Frequently asked questions
What does Surescripts actually do?
Surescripts operates the backbone network for U.S. medication-related health data exchange. It connects pharmacies, prescribers, health plans, pharmacy benefit managers, and EHR platforms to share structured clinical, benefit, and price intelligence. The network processed 30.5 billion transactions in 2025, encompassing e-prescribing, prior authorization, medication history, and care-team messaging.
Who governs Surescripts, and how is it funded?
Surescripts was originally formed by the merger of two pharmacy-industry e-prescribing networks and is now jointly owned by the National Association of Chain Drug Stores, the National Community Pharmacists Association, and several pharmacy benefit managers. It funds operations primarily through transaction fees paid by network participants. The governance model requires competing organizations — retail pharmacies, PBMs, health plans, and technology vendors — to collaborate on interoperability standards through the Surescripts Network Alliance.
How does Surescripts integrate with a provider's existing EHR workflow?
The network embeds intelligence directly into EHR workflows through certified integrations with major EHR vendors. Providers can access medication history, benefit and price transparency, and prior authorization submission tools without leaving their existing clinical screens. For EHR systems that lack native integration, Surescripts offers a standalone web-based Prior Authorization Portal.
What is the Surescripts Network Alliance?
The Network Alliance is the cross-industry collaboration body that unites pharmacies, PBMs, health plans, EHR vendors, prescribers, and public-health agencies that exchange data through Surescripts. Alliance participants work together to define data quality standards, launch new interoperability use cases — such as electronic case reporting and specialty medication workflows — and govern network integrity. The structure treats competitors as joint stewards of the shared infrastructure.
How does Surescripts handle prior authorization?
Surescripts automates prior authorization by pulling clinical documentation from the EHR at the moment of prescribing, matching it against payer-specific coverage rules, and returning an adjudicated response — often in real time — to the prescriber's workflow. The firm expanded this automation in 2026, reaching roughly 50% more prescribers nationwide by onboarding additional EHR and health-plan connections.
Does Surescripts sell or monetize patient data directly?
Surescripts generates revenue through network access and transaction fees, not through the sale of patient data. Its data-management framework operates under HIPAA compliance obligations and a stated stewardship model that prioritizes accuracy, trust, and network integrity. The Master Patient Index is used to link records for treatment coordination, not for commercial data brokerage.
What investment-stage or operator profile does Surescripts resemble as a private company?
Surescripts does not fit a traditional venture or growth-equity operating profile. It is a mature, industry-owned infrastructure utility with monopoly-like transaction volumes, deep regulatory entanglement, and cash-flow generation through recurring network fees. Any investor evaluating Surescripts typically treats it as critical national healthcare infrastructure rather than a conventional asset-manager or technology-portfolio candidate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: